Prosecution Insights
Prosecution Insights
5 pending office actions • 4 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready • 8 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 3 (60%) |
| §112 only | 1 (20%) |
| No statute on record | 1 (20%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MILLER, DALE R | 1 | 62.3% | +16.5% |
| SHIAO, REI TSANG | 1 | 80.0% | -34.5% |
| O DELL, DAVID K | 1 | 57.8% | +35.8% |
| ROZOF, TIMOTHY R | 1 | 72.6% | +24.0% |
| HUTTER, GILLIAN A | 1 | 54.9% | +46.1% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18278063 | S-CONFIGURATION-CONTAINING AMINO BENZAMIDE PYRIDAZINONE COMPOUND, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF | SHIAO, REI TSANG | 46d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17765354 | DRUG FOR TREATING ARTERY-RELATED DISEASES, AND USE THEREOF | HUTTER, GILLIAN A | 49d overdue |
| 18014932 | PENTACYCLIC TRITERPENOID GLYCOSIDE COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF | ROZOF, TIMOTHY R | 25d overdue |
| 18286416 | NUCLEOSIDE ANALOG AND USE THEREOF | MILLER, DALE R | 17d overdue |
| 18013696 | OXADIAZOLE COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND USE THEREOF | O DELL, DAVID K | 3d overdue |
| Art Unit | Apps |
|---|---|
| 1625 | 2 |
| 1693 | 1 |
| 1691 | 1 |
| 1621 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18286416 | NUCLEOSIDE ANALOG AND USE THEREOF | MILLER, DALE R | 1693 | Other | Non-Final OA | 17d overdue | Pending | Oct 11, 2023 |
| 18278063 | S-CONFIGURATION-CONTAINING AMINO BENZAMIDE PYRIDAZINONE COMPOUND, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF | SHIAO, REI TSANG | 1691 | §103 | Non-Final OA | 46d overdue | Pending | Aug 21, 2023 |
| 18013696 | OXADIAZOLE COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND USE THEREOF | O DELL, DAVID K | 1621 | §103 | Non-Final OA | 3d overdue | Pending | Aug 10, 2023 |
| 18014932 | PENTACYCLIC TRITERPENOID GLYCOSIDE COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF | ROZOF, TIMOTHY R | 1625 | §112 | Non-Final OA | 25d overdue | Pending | Jan 06, 2023 |
| 17765354 | DRUG FOR TREATING ARTERY-RELATED DISEASES, AND USE THEREOF | HUTTER, GILLIAN A | 1625 | §103 | Non-Final OA | 49d overdue | Pending | Mar 30, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial